BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32412315)

  • 1. Can miR-145-5p be used as a marker in diabetic patients?
    Shahrokhi SZ; Saeidi L; Sadatamini M; Jafarzadeh M; Rahimipour A; Kazerouni F
    Arch Physiol Biochem; 2022 Oct; 128(5):1175-1180. PubMed ID: 32412315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can circulating miR-7-1-5p, and miR-33a-5p be used as markers of T2D patients?
    Saeidi L; Shahrokhi SZ; Sadatamini M; Jafarzadeh M; Kazerouni F
    Arch Physiol Biochem; 2023 Jun; 129(3):771-777. PubMed ID: 33476198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches.
    Ghoreishi E; Shahrokhi SZ; Kazerouni F; Rahimipour A
    BMC Endocr Disord; 2022 Aug; 22(1):207. PubMed ID: 35978298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma miR-21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus.
    Yazdanpanah Z; Kazemipour N; Kalantar SM; Vahidi Mehrjardi MY
    Physiol Rep; 2022 Jan; 10(2):e15163. PubMed ID: 35076188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
    Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
    Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-135 May Serve as a Novel Co-biomarker of HbA1c in Type 2 Diabetes.
    Monfared YK; Honardoost M; Sarookhani MR; Farzam SA
    Appl Biochem Biotechnol; 2020 Jun; 191(2):623-630. PubMed ID: 31833019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.
    Yang Z; Chen H; Si H; Li X; Ding X; Sheng Q; Chen P; Zhang H
    Acta Diabetol; 2014 Oct; 51(5):823-31. PubMed ID: 24981880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.
    Prabu P; Rome S; Sathishkumar C; Aravind S; Mahalingam B; Shanthirani CS; Gastebois C; Villard A; Mohan V; Balasubramanyam M
    PLoS One; 2015; 10(5):e0128372. PubMed ID: 26020947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
    Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
    Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
    Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
    Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of miR-181b and miR-126-5p expression levels in T2DM patients compared to healthy individuals: Relationship with NF-κB gene expression.
    Dehghani M; Aghaei Zarch SM; Vahidi Mehrjardi MY; Nazari M; Babakhanzadeh E; Ghadimi H; Zeinali F; Talebi M
    Endocrinol Diabetes Nutr (Engl Ed); 2020; 67(7):454-460. PubMed ID: 31948856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Two-Diabetes Related microRNAs Suitability as Earlier Blood Biomarkers for Detecting Prediabetes and type 2 Diabetes Mellitus.
    Al-Muhtaresh HA; Al-Kafaji G
    J Clin Med; 2018 Jan; 7(2):. PubMed ID: 29373500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of salivary glucose assessment in diagnosis of diabetes and prediabestes.
    Fares S; Said MSM; Ibrahim W; Amin TT; Saad NES
    Diabetes Metab Syndr; 2019; 13(2):1543-1547. PubMed ID: 31336519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
    Wang J; Wang G; Liang Y; Zhou X
    J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
    Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
    Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-770-5p, miR-661 and miR-571 expression level in serum and tissue samples of foot ulcer caused by diabetes mellitus type II in Iranian population.
    VatanIman R; Malekpour SH; Afshari A; Zare M
    Mol Biol Rep; 2021 Dec; 48(12):7811-7818. PubMed ID: 34643918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
    Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Scorilas A; Fragoulis EG; Christodoulou MI
    Diabetes Res Clin Pract; 2020 Jun; 164():108187. PubMed ID: 32360711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
    Ren H; Wu C; Shao Y; Liu S; Zhou Y; Wang Q
    Front Med; 2020 Oct; 14(5):642-650. PubMed ID: 31950345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.